About
Adam Irving is a Senior Research Fellow at Monash University's Centre for Health Economics, specializing in health economics and decision modeling. He holds a PhD in Health Economics from Monash University (2020), an MSc in Health Economics & Decision Modelling from the University of Sheffield (2013), and a BEconSc in Economics from the University of Manchester (2009). His research focuses on optimizing healthcare resource allocation, particularly in haematology and blood transfusion practices. He leads the EpiMAP Myeloma project, developing disease pathway models for multiple myeloma using national registry data.
- Current Projects:
- Lead modeller for EpiMAP Myeloma (2024–2028)
- Chief Investigator in GLAM Study (Genomic Liquid Biopsy Analysis for Myeloma, 2024–2028)
- Co-Investigator in multiple blood management projects (e.g., OPTIMAL Immunoglobulin study)
His research interests span economic evaluations of clinical interventions, blood resource stewardship, and translational oncology economics. Recent work includes analyzing transfusion practices in cardiac surgery and sickle cell disease burden in Australia.
Publications highlight his expertise in cost-effectiveness analysis, disease modeling, and healthcare system optimization. Ongoing projects aim to refine guidelines for platelet transfusions and immunoglobulin use, with direct implications for UN SDG 3 (Good Health and Well-being).
- Grants & Collaborations:
- Projects funded by Australian research councils and partnerships with clinicians, statisticians, and industry
- Active collaborations across haematology, critical care, and public health disciplines
Labs/Teams: Central role in Monash’s Health Economics Centre and cross-faculty teams for disease modeling and translational research.
